3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Renal Cell
73
Neoplasm Metastasis
30
Kidney Neoplasms
26
Neoplasms
19
Breast Neoplasms
14
Prostatic Neoplasms
12
Urinary Bladder Neoplasms
10
Melanoma
9
Gastrointestinal Stromal Tumors
9
Brain Neoplasms
9
Glioblastoma
8
Sarcoma
7
Carcinoma, Non-Small-Cell Lung
7
Liver Neoplasms
6
Carcinoma, Hepatocellular
6
Recurrence
5
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Esophageal Neoplasms
5
Colorectal Neoplasms
5
Thyroid Neoplasms
4
Solid Tumors
4
Osteosarcoma
4
Lung Neoplasms
4
Leukemia, Myeloid, Acute
4
Adenocarcinoma
4
Uveal Melanoma
3
Thymoma
3
Stomach Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Sorafenib
4
Blood Specimen Collection
4
lenvatinib
3
sintilimab
2
halofantrine
2
camrelizumab
2
Liver Transplantation
2
Antibodies
2
trametinib
1
toripalimab
1
titanium silicide
1
tislelizumab
1
pembrolizumab
1
ledipasvir, sofosbuvir drug combination
1
genexol-PM
1
gadolinium ethoxybenzyl DTPA
1
fluorocholine
1
bavituximab
1
avatrombopag
1
aumolertinib
1
atezolizumab
1
User-Centered Design
1
Sunitinib
1
Sufentanil
1
Sofosbuvir
1
Shadowing Technique, Histology
1
Ropivacaine
1
Ribavirin
1
Radiotherapy
1
Radiosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Liver Diseases
×
Sunitinib
×
Clear all
NCT01215565
2014-03-13
Fibrolam
Assistance Publique - Hôpitaux de Paris
Phase 2
Terminated
4 enrolled